Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages

K L McCoy1, D Gainey, G A Cabral

  • 1Department of Microbiology and Immunology, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.

The Journal of Pharmacology and Experimental Therapeutics
|June 1, 1995
PubMed
Summary

Delta-9-Tetrahydrocannabinol (THC) impacts macrophage immune functions. THC differentially affects how macrophages process antigens, crucial for activating CD4+ T cells, by primarily impairing antigen processing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Does immune dysfunction persist into adulthood after adolescent use of marijuana?

Journal of leukocyte biology·2014
Same author

Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.

Endocrine, metabolic & immune disorders drug targets·2008
Same author

CB2 receptors in the brain: role in central immune function.

British journal of pharmacology·2007
Same author

The interaction between the amoeba Balamuthia mandrillaris and extracellular matrix glycoproteins in vitro.

Parasitology·2006
Same author

Effects on the immune system.

Handbook of experimental pharmacology·2006
Same author

Cannabinoid receptors in microglia of the central nervous system: immune functional relevance.

Journal of leukocyte biology·2005

Area of Science:

  • Immunology
  • Neuroscience
  • Pharmacology

Background:

  • Delta-9-Tetrahydrocannabinol (THC), a primary psychoactive component of cannabis, is known to suppress various immune functions.
  • Macrophages play a critical role in the immune system, particularly in processing and presenting antigens to T cells.
  • Understanding THC's specific effects on macrophage antigen processing is essential for evaluating its immunological impact.

Purpose of the Study:

  • To investigate the effect of delta-9-Tetrahydrocannabinol (THC) on the capacity of macrophages to process and present soluble protein antigens.
  • To determine if THC's influence on antigen presentation is specific to certain antigens or processing pathways.
  • To elucidate the mechanism by which THC modulates macrophage function in relation to T cell activation.

Main Methods:

Related Experiment Videos

  • Macrophage hybridomas were pretreated with THC for 24 hours.
  • Antigen-specific helper T cell hybridomas were used to assess interleukin-2 secretion, indicating T cell activation.
  • THC's effects were evaluated on the processing of hen egg lysozyme and chicken ovalbumin, and presentation of pigeon cytochrome c peptides.

Main Results:

  • THC pretreatment significantly reduced T cell response to hen egg lysozyme, indicating impaired antigen processing.
  • THC did not affect the processing of chicken ovalbumin but augmented antigen presentation for pigeon cytochrome c.
  • Inhibition of T cell activation by peptides (not requiring processing) occurred only at high THC concentrations, suggesting a primary effect on antigen processing rather than T cell viability or general antigen presentation.

Conclusions:

  • Delta-9-Tetrahydrocannabinol (THC) differentially modulates the antigen processing capacity of macrophages.
  • THC's primary impact appears to be on the processing step of antigen presentation, rather than T cell viability or direct T cell activation.
  • These findings highlight a specific mechanism by which THC can suppress adaptive immune responses mediated by CD4+ T cells.